Pharmaceutical agents and pregnancy in urology practice.
Urologic medical conditions are not frequently encountered during pregnancy. Still, urologists often are asked to treat pregnant patients for conditions that require prescriptions. In the generally healthy population of pregnant women, the use of pharmaceutical agents is usually reserved for women who have either infections or necessary surgical procedures. This article addresses the implications for pregnancy of common urologic conditions in generally healthy pregnant women, namely simple urinary tract infections that demand nitrofurantoin and complex urinary tract infections that necessitate fluoroquinolones treatment. It also examines the implications of nonobstetric surgical intervention.
Shrim
Alon
A
The Motherisk Program, Division of Clinical Pharmacology/Toxicology, Hospital for Sick Children, The University of Toronto, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8.
Garcia-Bournissen
Facundo
F
Koren
Gideon
G
D005260:Female; D005333:Fetus / Q000187:drug effects; D024841:Fluoroquinolones / Q000009:adverse effects; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000601:surgery; D012307:Risk Factors; D014570:Urologic Diseases / Q000188:drug therapy* / Q000601:surgery; D013520:Urologic Surgical Procedures / Q000009:adverse effects
D024841:Fluoroquinolones